Technical Report Dermatology
Rethinking falls in critically ill adults: the role of an enhanced recovery pathway

Rethinking falls in critically ill adults: the role of an enhanced recovery pathway

Authors

Lucas Novak

Lucas Novak

Hamad Medical Corporation, Iceland

Leo Rossi

Leo Rossi

Royal Melbourne Hospital, Cayman Islands

Arjun Yilmaz

Arjun Yilmaz

Cleveland Clinic Abu Dhabi, Fiji Islands

Freya Patel

Freya Patel

Aga Khan University Hospital, Mayotte

James Costa

James Costa

Singapore General Hospital, Saint-Martin (French part)

Noura Rossi

Noura Rossi

Mayo Clinic, Nepal

Corresponding

Published

July 19, 2025

Paper ID

PAP-000209

Status

Published

DOI

10.65712/tmj.test000467

Rethinking falls in critically ill adults: the role of an enhanced recovery pathway

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of falls to health systems is substantial. Methods: Eligible participants were critically ill adults. Results: Effects were consistent across prespecified subgroups. 4545 participants were included (median age 38 years). Conclusion: Future work should test an enhanced recovery pathway in a pragmatic multicentre trial.

Introduction

Practice around an enhanced recovery pathway varies widely between centres. falls remains a leading cause of avoidable harm among critically ill adults.

falls remains a leading cause of avoidable harm among critically ill adults. Practice around an enhanced recovery pathway varies widely between centres. Earlier studies of an enhanced recovery pathway were small or single-centre.

The cost of falls to health systems is substantial.

The cost of falls to health systems is substantial. Practice around an enhanced recovery pathway varies widely between centres.

Discussion

Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Implementation will depend on staffing, cost and local protocols. Future work should test an enhanced recovery pathway in a pragmatic multicentre trial.

Conclusions

An enhanced recovery pathway may be offered for critically ill adults to improve falls.

References

1. Zhang L, Herrera E, et al. Vitamin D supplementation and in-hospital mortality. Lancet. 2010;113(6):505-1620.

2. Mueller F, Mensah Z, et al. Vitamin D supplementation and health-related quality of life. Ann Intern Med. 2022;133(4):330-977.

3. Volkov A, Rossi Q, et al. An enhanced recovery pathway and chronic pain scores. Pediatrics. 2022;125(11):521-1237.

4. Ahmed B, Zhang N, et al. Early enteral nutrition and falls. Ann Intern Med. 2025;291(5):26-1360.

5. Schmidt P, Kowalski P, et al. Point-of-care ultrasound and medication adherence. Lancet. 2018;387(10):726-1050.

6. Moreau G, Kaur V, et al. Machine-learning triage and patient satisfaction. BMJ. 2023;341(11):650-1687.

7. Moreau H, Patel V, et al. Early enteral nutrition and post-operative delirium. Ann Intern Med. 2018;300(11):207-911.

8. Nasser W, Rossi Y, et al. Nurse-led discharge planning and ventilator-free days. N Engl J Med. 2020;76(10):233-913.

Appendices

Ethics approval: IRB-1054.

Materials and Methods

Missing data were handled with multiple imputation. We conducted a quality-improvement audit across 9 centres between 2017 and 2022. Eligible participants were critically ill adults.

Eligible participants were critically ill adults. We conducted a quality-improvement audit across 10 centres between 2016 and 2021.

Missing data were handled with multiple imputation. The primary outcome was falls, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.

Results

Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.

GroupnEventsRate %OR
Centre B2293130.30.87
Control303788.80.67
Male5564919.10.81
Control6695036.10.88
Female196588.60.81
Male854704.80.60
Centre B1445039.60.74
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in falls
Shown for critically ill adults; error bars are 95% confidence intervals.

2838 participants were included (median age 32 years). Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.41 (95% CI 0.36 to 0.80).